RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:300557

Carcinoma of the ampulla of Vater

high confidenceDisorder

Also known as: Ampulloma · Ampullary carcinoma

Publications

3,144

94.7th percentile

Trials

9

Interventional, condition-specific

Researchers

1,443

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

Carcinoma of the ampulla of Vater is a rare malignant tumor originating from the ampulla of Vater that can present with symptoms of general fatigue, loss of appetite, weight loss, nausea, vomiting, abdominal pain and, most commonly, painless obstructive jaundice. The tumor is believed to arise from duodenal, biliary or pancreatic epilthelium, resulting in the respective histological types. In general, carcinoma of the ampulla of Vater has a better prognosis (5-year survival rate of 45%) than cancers of the distal bile duct and pancreas.

How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (5)

ampulla of Vater carcinoma · ampullary carcinoma · carcinoma of ampulla of vater · carcinoma of hepatopancreatic ampulla · hepatopancreatic ampulla carcinoma

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    3,144 matched papers (1,553 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    9 matched on ClinicalTrials.gov (5 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

3,144

3,144 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

3,144 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

1,553 in the last 10 years · high confidence · 94.7th percentile (publications denominator)

Phrase hits: 3,144 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,443

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Suzuki Y7 papers · 2026

    Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.

    Papers in Europe PMC
  2. 02
    Liu Y5 papers · 2026

    School of Pharmacy, Lanzhou University, No. 199 Donggang West Road, Lanzhou 730000, PR China. Electronic address: yqliu@lzu.edu.cn.

    Papers in Europe PMC
  3. 03
    Maeda S5 papers · 2026

    Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

    Papers in Europe PMC
  4. 04
    Ashida R4 papers · 2024

    Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

    Papers in Europe PMC
  5. 05
    Endo K4 papers · 2026

    Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.

    Papers in Europe PMC
  6. 06
    Kobayashi T4 papers · 2026

    Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.

    Papers in Europe PMC
  7. 07
    Liu J4 papers · 2026

    Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, 430022, Wuhan, China.

    Papers in Europe PMC
  8. 08
    Miwa H4 papers · 2026

    Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.

    Papers in Europe PMC
  9. 09
    Ohgi K4 papers · 2024

    Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

    Papers in Europe PMC
  10. 10
    Oishi R4 papers · 2026

    Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

9

interventional trials for this specific condition

9 interventional trials matched this specific condition name; 5 currently recruiting in our sample.

Data as of 27 July 2026

9 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 91.2th percentile).

high confidence · 91.2th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

9 interventional trials matched after quoted-phrase search and title/condition post-filter.

Observational and natural-history studies

2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

None of the matched observational studies is currently listed as recruiting.

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Carcinoma of the ampulla of Vater" OR "Carcinoma of ampulla of Vater" OR "Ampulloma" OR "Ampullary carcinoma" OR "ampulla of Vater carcinoma" OR "ampulla of the Vater carcinoma" OR "carcinoma of the ampulla of the vater" OR "carcinoma of hepatopancreatic ampulla" OR "carcinoma of the hepatopancreatic ampulla" OR "hepatopancreatic ampulla carcinoma"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Carcinoma of the ampulla of Vater" OR "Carcinoma of ampulla of Vater" OR "Ampulloma" OR "Ampullary carcinoma" OR "ampulla of Vater carcinoma" OR "ampulla of the Vater carcinoma" OR "carcinoma of the ampulla of the vater" OR "carcinoma of hepatopancreatic ampulla" OR "carcinoma of the hepatopancreatic ampulla" OR "hepatopancreatic ampulla carcinoma"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 9 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T12:42:11.984Z